Nexome Capital Markets Board to Vote on Warrant Conversion Share Allotment

Nexome Capital Markets Limited has scheduled a Board of Directors meeting for April 20, 2026. The primary agenda is to consider and approve the allotment of equity shares from outstanding warrants converted on a preferential basis. This action follows SEBI Listing Regulations. The board's approval will increase the company's equity share capital. Nexome Capital Markets had previously informed BSE Limited about this meeting on April 15, 2026, as per Regulation 29 of SEBI Listing Regulations.

Why This Matters

The board meeting could alter Nexome Capital Markets' capital structure. Approving the warrant conversion to equity shares on a preferential basis could bolster the company's equity base. This process is governed by SEBI's ICDR (Issue of Capital and Disclosure Requirements) Regulations, ensuring fair pricing and regulatory compliance.

A preferential issue allows a company to raise capital by issuing shares or other securities to a select group of investors at a predetermined price. Warrant conversion is a mechanism where holders exercise their right to buy shares, thereby increasing the company's outstanding equity.

Company Background

Nexome Capital Markets, previously known as SMIFS Capital Markets Limited, has engaged in various capital-raising efforts. In October 2024, the company allotted equity shares and convertible warrants through a preferential issue. More recently, in March 2026, the company undertook a Rights Issue to raise approximately ₹22.04 Crores.

However, the company has faced significant financial challenges. For the fiscal year ending March 31, 2025 (FY25), Nexome Capital Markets reported a steep decline in consolidated revenue to ₹44.41 Crores, a sharp drop from ₹239.86 Crores in FY24. Profit After Tax (PAT) also fell by 52% year-on-year. Compounding these challenges, total borrowings surged from ₹9.31 Lakhs in FY24 to ₹30.02 Crores in FY25.

Nexome Capital Markets has also faced regulatory scrutiny. Past SEBI penalties for non-disclosure and issues with its Merchant Banker Certificate suggest potential compliance or governance concerns.

What This Means

• Board Decision: The board will decide on the warrant conversion and share allotment on April 20, 2026.
• Increased Equity: Approval would raise the company's equity share capital, potentially strengthening its balance sheet.
• Shareholder Dilution: Existing shareholders could see their stake diluted if the conversion price is below the market price.
• Further Filings: Post-approval, additional regulatory filings will be required to finalize the allotment.

Risks to Watch

• Financial Pressures: The steep revenue and profit drop in FY25, alongside higher borrowings, signals ongoing financial challenges requiring attention.
• Compliance Concerns: The company's past SEBI penalties and Merchant Banker Certificate issues highlight potential governance or compliance risks that need careful monitoring.
• Execution Risk: The success of the share allotment and its impact on financial health will depend on conversion terms and future operations.

Peer Comparison

Nexome Capital Markets operates within India's diverse capital markets and financial services sector. Key players in this space include entities like BSE, HDFC AMC, Motilal Oswal Financial Services, Anand Rathi Wealth, and IIFL Securities, which offer a range of services from exchange operations to investment banking and wealth management.

What to Track Next

• Board Outcome: Watch the results of the April 20, 2026, board meeting on warrant conversion approval.
• Allotment Specifics: Look for details on the share allotment, including share numbers, conversion price, and total capital raised.
• Regulatory Updates: Follow subsequent filings with SEBI and stock exchanges for allotment process updates.
• Future Performance: Monitor the company's financial results and strategies after allotment to see how it uses the new capital.